Connection
David Ivy to Product Surveillance, Postmarketing
This is a "connection" page, showing publications David Ivy has written about Product Surveillance, Postmarketing.
|
|
Connection Strength |
|
|
|
|
|
0.106 |
|
|
|
-
Maxey DM, Ivy DD, Ogawa MT, Feinstein JA. Food and Drug Administration (FDA) postmarket reported side effects and adverse events associated with pulmonary hypertension therapy in pediatric patients. Pediatr Cardiol. 2013 Oct; 34(7):1628-36.
Score: 0.106